Cargando…
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
Current pharmacological treatments of axial spondyloarthritis (axSpA) are limited to non-steroidal anti-inflammatory drugs (NSAIDs) and biological agents, including TNFα inhibitors and IL-17 inhibitors. Despite the availability of these agents, many patients either fail to respond adequately, lose t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951918/ https://www.ncbi.nlm.nih.gov/pubmed/35337068 http://dx.doi.org/10.3390/ph15030270 |